David Gallagher

David Gallagher is a European and Chartered (UK) Patent Attorney at J A Kemp's Biotechnology and Life Sciences Group in Cambridge.

He specializes in drafting, filing, and prosecuting patent applications in areas such as therapeutic antibodies, peptides, diagnostic methods, enzymes, and vaccines.

David works with a diverse range of clients, including universities, SMEs, and multinational pharmaceutical companies, managing large patent families across various jurisdictions.

His experience includes prosecuting applications at regional and national patent offices in Africa, South America, and Eurasia, as well as handling opposition proceedings at the European Patent Office.

He has a strong background in preparing freedom-to-operate reports for spin-out companies seeking investment.

David Gallagher holds a PhD in Structural Biology from the University of Cambridge, a Postgraduate Certificate in Intellectual Property Law from Queen Mary University of London, and a First Class Honours MBiochem in Biochemistry, Biophysics, and Molecular Cell Biology from the University of Oxford.

His professional journey includes roles as a Patent Attorney, European Patent Attorney, Trainee Patent Attorney at J A Kemp, along with positions at D Young & Co LLP, MRC Mitochondrial Biology Unit, and Wellcome Trust Centre for Human Genetics.

He also gained industry experience through summer placements and as a placement student at Eli Lilly and Company.

For more information, visit his profile at J A Kemp's website: https://www.jakemp.com/en/attorney/David-Gallagher